Myovant Sciences Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Myovant Sciences Ltd. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $8.41 per share as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2022-05-11
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.41.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.77.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.13.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.11.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-03-31 | $8.41 10-K · filed 2022-05-11 |
| 2021-03-31 | $9.77 10-K · filed 2021-05-11 |
| 2020-03-31 | $8.13 10-K · filed 2020-05-18 |
| 2019-03-31 | $9.11 10-K · filed 2019-05-24 |
| 2018-03-31 | $4.88 10-K · filed 2018-06-07 |
| 2017-12-31 | $9.47 10-Q · filed 2018-02-13 |
| 2017-09-30 | $9.22 10-Q · filed 2017-11-13 |
| 2017-03-31 | $11.19 10-K · filed 2017-06-14 |